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COMMENTARY Open Access
Patient involvement in questionnaire
design: tackling response error and burden
Marissa Ayano Mes1 , Amy Hai Yan Chan1, Vari Wileman1, Caroline Brigitte Katzer1, Melissa Goodbourn2,3,
Steven Towndrow4, Stephanie Jane Caroline Taylor5 and Rob Horne1*
Abstract
Questionnaires capture patient perspectives succinctly and at relatively low cost, making them a popular data
collection tool for health researchers. However, questionnaire data can be affected by response error and response
burden. Patient involvement during questionnaire design can help reduce the effect of response error and burden.
This paper describes a novel approach for patient involvement during questionnaire design, combining methods
from cognitive interviewing (Think Aloud Tasks) with an open-ended follow-up discussion to collate and act on
patient feedback, while also taking account of the common challenges in questionnaire design (i.e. response error
and burden). The strengths and limitations of this approach are discussed, and recommendations are made for
future use.
Keywords: Patient and public involvement (PPI), Think Aloud Tasks (TATs)., Cognitive Interviewing., Questionnaire
Design.
Plain english summary
Health researchers often use questionnaires to collect
data. When patients fill in questionnaires, they may
interpret the questions differently from how the re-
searchers intended. This is an example of response
error. Answers can also be affected by how much ef-
fort it takes to fill in the questionnaire, this is called
response burden. For example, patients may pay less
attention at the end of a long questionnaire. Involving
patients in questionnaire design is important because
it can help prevent response error and burden. This
paper describes a new way of gathering patient feed-
back during questionnaire design, which combines
techniques used in research with an open-ended dis-
cussion. It describes the strengths and weaknesses of
this approach, and outlines tips for researchers and
patients involved in questionnaire design.
Introduction
Patient and Public Involvement (PPI) refers to “re-
search being carried out ‘with’ or ‘by’ members of the
public, rather than ‘to’, ‘about’ or ‘for’ them”. It is an
integral part of healthcare policy and research guid-
ance [1]. An example of PPI is when patient contrib-
utors provide feedback to develop new research
materials such as questionnaires. Involving patients
while designing new questionnaires improves ques-
tionnaire comprehensiveness and relevance, and re-
duces item ambiguities [2, 3].
In health research, key challenges in questionnaire
design include response error and response burden
[4–7]. Response error occurs when a questionnaire
item or the way a respondent processes the item re-
sults in an inaccurate answer [6]. Response burden
refers to the effort required to complete the question-
naire, determined by factors such as the emotional/
cognitive load of items, questionnaire length, layout,
or distribution method [6, 7].
In this commentary, we describe a novel approach
for tackling the aforementioned challenges and facili-
tating PPI in questionnaire design. By drawing on
methods previously used in cognitive interviewing, we
aimed to identify potential sources of response error/
burden and generate an initial springboard for add-
itional discussion between researchers and patient
contributors. The commentary acts as an illustrative
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case of health-related questionnaire design, including
key insights, resources from the literature, and recom-




We designed an intervention targeting medication ad-
herence in adults with asthma, to be delivered by
general practice pharmacists. To explore the perspec-
tives of adults with asthma on this new intervention,
we wanted to design a questionnaire that measured
intervention acceptability. Acceptability refers to how
appropriate patients feel an intervention is, based on
experienced or anticipated cognitive/emotional re-
sponses [8].
Designing the questionnaire
The first version of the acceptability questionnaire
was drafted by researchers based on the Theoretical
Framework of Acceptability (TFA), focusing on inter-
vention content and delivery (i.e. by pharmacists)
[8]. Four members of the Asthma UK Centre for Ap-
plied Research (AUKCAR) Patient Advisory Group
agreed to help refine the questionnaire as patient
contributors. The AUKCAR Patient Advisory Group
consists of adults with lived experience of asthma
who offer advice and guidance on incorporating pa-
tient perspectives into all stages of research.
Feedback was gathered over the telephone, enab-
ling contributors from across the United Kingdom
(UK) to be involved. The telephone calls were
audio-recorded for our records and detailed summar-
ies of patient feedback were written. Drawing on
cognitive interviewing methodology, we began with a
Think Aloud Task (TAT) based on recommendations
by van Someren MW, Barnard YF and Sandberg JAC
[9]. Contributors were asked to continuously verbal-
ise their thought process as they worked through the
questionnaire. This helped researchers understand
how people interpreted, processed, and responded to
questionnaire items [9]. Researchers and contributors
then picked up on issues emerging from the TATs in
an open-ended follow-up discussion, where contribu-
tors were also encouraged to bring up any additional
issues they found relevant. Patient contributors were
e-mailed TAT instructions and background informa-
tion on the intervention ahead of time. To ensure
that contributors felt comfortable with the TAT pro-
cedure, an unrelated questionnaire about job satis-
faction was used to practice. We did not e-mail the
acceptability questionnaire to the contributors until
directly before the telephone call to ensure that the
TAT was based on their first impressions. Patient
contributors’ feedback was incorporated into a new
questionnaire draft (see Table 1 for examples). To
keep patient contributors informed, we produced a
brief summary of their feedback and how it was in-
corporated into the new questionnaire. This was
e-mailed to them, in case of further comments.
Key insights and recommendations
Two patient contributors reflected on the question-
naire design process with the researchers to identify
the strengths and limitations of our novel PPI ap-
proach (TATs paired with an open-ended discussion).
Recommendations for this approach are highlighted
in Table 2.
A key strength of the TAT is the fact that it struc-
tures the initial feedback process. Patient contributors
mentioned that this may be a useful approach for
people who initially struggle with open-ended ques-
tions. The TAT also facilitated researcher and con-
tributor communication by acting as a springboard
for the open-ended follow-up discussion: researchers
picked up on issues identified in the TAT for further
discussion with the contributors.
However, a potential limitation of the approach is
that contributors may have limited experience with
TATs, and this may act as a barrier to feedback. We
Table 1 Examples of patient contributors’ feedback and the associated changes to the questionnaire
Identified in Example of Feedback given Changes made
TAT Response error In the medication adherence literature, “concerns”
refer to medication-related negative effects [10].
However, patient contributors interpreted the
item “I am concerned about my preventer inhaler”
as “I care about my preventer inhaler”.
The item wording was changed to “I am worried
about taking my preventer inhaler”.
Follow-up discussion External factors The questionnaire was designed for completion
in a general practice waiting room. While patient
contributors felt that the instructions on the
questionnaire were clear, they noted that
elements of the waiting rooms (e.g. ambient
noise or waiting to be called in) may distract
respondents from reading the instructions thoroughly.
The questionnaire instructions were shortened
and illustrations were added to provide crucial
information in a single glance.
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followed recommendations made by van Someren
MW, Barnard YF and Sandberg JAC [9] regarding
clear TAT instructions: asking contributors to con-
tinuously say what was going through their minds
with limited pauses, rather than asking for evalu-
ation (e.g. “what do you think about…”). A practice
TAT with an unrelated questionnaire also helped
contributors familiarise themselves with the proced-
ure [9]. We tried to overcome the limitations associ-
ated with the TATs with an open-ended follow-up
discussion, which tackled issues that had not been
identified in the TAT procedure (e.g. external fac-
tors) (see Table 1). Furthermore, employing multiple
feedback methods ensured that contributors were
able to offer feedback in a way that was comfortable
for them.
Underpinning this entire process was the rapport
between researchers and patient contributors. Con-
tributors emphasized the importance of investing ad-
equate time to establish rapport before gathering
feedback. Contributors that feel comfortable with re-
searchers may provide more detailed feedback, and
giving contributors a positive PPI experience may
encourage future research involvement. Minimising
researcher interruption during both the TAT and the
follow-up discussion signalled to the contributors
that their time to speak was valued and respected.
Conclusion
As well as tackling common issues in questionnaire de-
sign (e.g. response error), the novel approach outlined in
this commentary also incorporated people’s lived experi-
ences of a long-term condition and potential study set-
tings (e.g. general practice waiting rooms) into the
questionnaire design process. Using methods previously
employed in cognitive interviewing, researchers and pa-
tient contributors were able to create an initial spring-
board for further discussion. This unique combination
of feedback methods may help researchers collate and
act on patient feedback, while also taking account of the
common challenges in questionnaire design (i.e. re-
sponse error and burden). For patient contributors in-
volved in questionnaire design, having a clear-cut
process for feedback may also improve the PPI experi-
ence. These benefits may encourage increased PPI in
questionnaire design, and reduce the risk of making
questionnaires overly complex.
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Table 2 Key recommendations from researchers and patient
contributors about the novel approach (TATs and follow-up
discussion) for patient involvement in questionnaire design
Key Recommendations Description
Clear TAT instructions • Ask contributors to continuously say what
is going through their minds with limited
pauses.
• Avoid asking for evaluation (e.g. “tell me
what you think about…”).
• Always ask if contributors have any
questions about the TAT procedure.
Practice TAT • Practice TATs with another questionnaire
(similar structure, different topic).
• Jointly reflect on the practice exercise
with the contributor.
• Aim for minimal researcher interruptions
during the practice task.
Multiple feedback
methods
• Contributors may not feel comfortable
with certain feedback methods (e.g. TATs).
• When using TATs, always have alternative
feedback methods available (e.g. open-
ended feedback sessions).
• Use structured feedback methods
(e.g. TATs) as a springboard for other
feedback methods (e.g. open-ended
discussion).
Good rapport • Establish good researcher – contributor
rapport before gathering feedback.
• Making contributors feel comfortable
will generate more detailed feedback.
• Making sure contributors have a positive
PPI experience will benefit future research
(e.g. with their continued involvement in
other studies).
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